CTS Corp director gets 3,500 RSU shares; now owns 101,742
CTS Corp (CTS) director Robert Profusek reported acquiring 3,500 shares of common stock on 11/06/2025 at $0.
Rhea-AI Filing Summary
CTS Corp (CTS) director Robert Profusek reported acquiring 3,500 shares of common stock on 11/06/2025 at $0. The award reflects restricted stock units that vest 100% on the first anniversary of the grant date, contingent on continued service as a director.
Following the transaction, Profusek beneficially owns 101,742 shares directly and 1,800 shares indirectly through a spouse. The filing was made by one reporting person.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 3,500 shares
Grant/Award
2 txns
Insider
PROFUSEK ROBERT
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3,500 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 101,742 shares (Direct);
Common Stock — 1,800 shares (Indirect, By Spouse)
Footnotes (1)
- F1. Restricted stock units vest 100% on the first anniversary of the grant date, contingent upon the recipient's continued service as a director through the vesting date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CTS (CTS) report on Form 4?
Director Robert Profusek acquired 3,500 shares of common stock on 11/06/2025 at $0 via an RSU award.
How do the RSUs for CTS (CTS) vest?
They vest 100% on the first anniversary of the grant date, contingent on continued service as a director.
What is the insider’s relationship to CTS (CTS)?
The reporting person is a Director of CTS Corp.
Was this filing made by multiple reporting persons?
No. It was filed by one reporting person.
Who signed the Form 4 for CTS (CTS)?
It was signed by /s/ Debra S. Rouse, attorney-in-fact for Robert Profusek, dated 11/10/2025.
AI-generated analysis. How Rhea-AI works. Not financial advice.